학술논문
Sustained Response After Remdesivir and Convalescent Plasma Therapy in a B-Cell–Depleted Patient With Protracted Coronavirus Disease 2019 (COVID-19).
Document Type
Article
Author
Source
Subject
*THERAPEUTIC use of monoclonal antibodies
*COVID-19
*B cells
*ANTIVIRAL agents
*TREATMENT effectiveness
*CONVALESCENT plasma
*VIREMIA
*LYMPHOMAS
*
*
*
*
*
*
*
Language
ISSN
1058-4838
Abstract
We provide detailed clinical, virological, and immunological data of a B-cell–depleted patient treated with obinutuzumab for follicular lymphoma with protracted coronavirus disease 2019 (COVID-19) and viremia. A sustained response was achieved after 2 courses of remdesivir and subsequent convalescent plasma therapy. Immunocompromised patients might require combined and prolonged antiviral treatment regimens. [ABSTRACT FROM AUTHOR]